Retinal Disorders Archives

Hyperbaric oxygenation combined with nifedipine treatment for recent-onset retinal artery occlusion.

Apr 1, 1993 | Central Retinal Artery Occlusion (CRAO)

Abstract: We describe the results of early hyperbaric oxygenation combined with nifedipine treatment for central retinal artery occlusion, and explain the results pathophysiologically. We report four cases in which hyperbaric oxygenation therapy was applied in...

Correlation of electroretinographic changes with visual prognosis in central retinal artery occlusion.

Jan 1, 1993 | Central Retinal Artery Occlusion (CRAO)

Abstract: Recent advances in the treatment of central retinal artery occlusion (CRAO) have resulted in a relatively good prognosis, but few studies have been reported. In the present study, electroretinography (ERG) was used to evaluate visual function recovery in 15...

Retinal artery occlusion in a diver.

Jun 1, 1992 | Central Retinal Artery Occlusion (CRAO)

Abstract: The clinical manifestation of decompression disorders is highly variable, ranging from mild rashes or joint pains to central nervous system symptoms like scotomata, paralysis and death. The diagnosis is easily overlooked, especially if an occupational...

[Hyperbaric oxygen treatment for cystoid macular edema secondary to retinal vein occlusion].

Jul 1, 1991 | Macular Degeneration

Abstract: A prospective study was made to estimate the effect of hyperbaric oxygen (HBO) on 14 eyes of cystoid macular edema (CME) secondary to retinal vein occlusion. The visual acuity was improved 2-6 lines (average 3.6 lines) after the treatment, while the control...

Bifemelane in the treatment of central retinal artery or vein obstruction.

May 1, 1990 | Central Retinal Artery Occlusion (CRAO)

Abstract: Patients with retinal artery or vein obstruction received 150 mg of bifemelane hydrochloride daily for 1 to 11 months and other treatment (urokinase, steroid hormone, hyperbaric oxygen, or laser photocoagulation) or the latter without bifemelane. After...

Research in Ohio.

Mar 1, 1989 | Macular Degeneration

Abstract: Edwards, , , , , , , , (1989). Research in Ohio. Ohio medicine : journal of the Ohio State Medical Association, 1989 Mar;85(3):182. https://www.ncbi.nlm.nih.gov/pubmed/2726133

[Visual improvement in diabetic macular edema by hyperbaric oxygen treatment].

Sep 1, 1988 | Macular Degeneration

Abstract: Ogura, Kiryu, Takahashi, Honda, , , , , (1988). [Visual improvement in diabetic macular edema by hyperbaric oxygen treatment]. Nippon Ganka Gakkai zasshi, 1988 Sep;92(9):1456-60. https://www.ncbi.nlm.nih.gov/pubmed/3213778

Hyperbaric oxygen treatment for chronic cystoid macular edema after branch retinal vein occlusion.

Sep 15, 1987 | Macular Degeneration

Abstract: Ogura, Takahashi, Ueno, Honda, , , , , (1987). Hyperbaric oxygen treatment for chronic cystoid macular edema after branch retinal vein occlusion. American journal of ophthalmology, 1987 Sep;104(3):301-2. https://www.ncbi.nlm.nih.gov/pubmed/3631188

Preliminary report on the effect of hyperbaric oxygen on cystoid macular edema.

Mar 1, 1987 | Macular Degeneration

Abstract: The treatment of established cystoid macular edema has been enigmatic. This is a preliminary study of five patients treated by intermittent hyperbaric oxygen with an intensive regimen of 1.5 hours two times per day for seven days and two hours per day for an...

[Maculopathy in typical retinitis pigmentosa apropos of 33 cases].

Jan 1, 1987 | Macular Degeneration

Abstract: The authors studied 33 maculopathies in 54 patients affected by typic retinitis pigmentosa: atrophic macular degeneration 31 cases (49%); cystoïd macular oedema: 1 case (3%) and macular retraction syndrome: 1 case (3%). These results are confronted with...